Back to Search Start Over

Current marijuana use among women of reproductive age

Authors :
Gillian L. Schauer
Alexander C. Ewing
Althea M. Grant-Lenzy
Jean Y. Ko
Kelsey C. Coy
Rashid Njai
Source :
Drug and Alcohol Dependence. 214:108161
Publication Year :
2020
Publisher :
Elsevier BV, 2020.

Abstract

Background The objective of this study was to estimate the prevalence of current (past 30 days) marijuana use and its associations with demographic, other substance use, chronic disease, physical health and mental health measures among women of reproductive age (18–44 years) in 12 US states. Methods This analysis used 2016 Behavioral Risk Factor Surveillance System (BRFSS) data from 16,556 women of reproductive age in 12 US states. Women self-reported current marijuana use and covariates. Weighted χ2 statistics and adjusted prevalence ratios (aPR) were calculated accounting for the complex survey design. Results Among women of reproductive age, 9.9 % reported current marijuana use. Current cigarette use (aPR: 2.0, 95 % CI: 1.6, 2.6), current e-cigarette use (aPR: 1.9, 95 % CI: 1.4, 2.6), binge drinking (aPR: 2.6, 95 % CI: 1.9, 3.6), ever having received a depression diagnosis (aPR: 1.6, 95 % CI: 1.2, 2.1), and ≥14 days of poor mental health in the past 30 days (aPR: 1.8, 95 % CI: 1.3, 2.4) were all associated with higher adjusted prevalence of current marijuana use. Reporting ≥14 days of poor physical health within the last 30 was associated with a 40 % lower adjusted prevalence of current marijuana use (aPR: 0.6, 95 % CI: 0.4, 0.8). Conclusion Current marijuana use among women of reproductive age was associated with other substance use, poor mental health, and depression. As state laws concerning marijuana use continue to change, it is important to monitor usage patterns and to assess associated health risks in this population.

Details

ISSN :
03768716
Volume :
214
Database :
OpenAIRE
Journal :
Drug and Alcohol Dependence
Accession number :
edsair.doi.dedup.....da6bbb86a9f5d441726f646e417fe00f
Full Text :
https://doi.org/10.1016/j.drugalcdep.2020.108161